Latest News

  • Epigenetic Biomarkers Needed For Shift From Treatment To Prevention

    Diagnostics World | There is mounting evidence that epigenetics—the molecular processes that influence how genes are expressed—is an equally if not more important driver of disease conditions and phenotypic differences than genetics. That means that accelerating the shift from reactionary medicine to preventive care is going to require biomarkers of these heritable and reversible changes.

    Dec 21, 2023
  • NIH Program Tackles Bottlenecks In ‘Wild West’ Field Of exRNA Biology

    Diagnostics World | A decade ago, the National Institutes of Health (NIH) launched a program designed to answer fundamental questions about extracellular RNA (exRNA), such as how it is used by cells and distant organs and if diseased and healthy cells produce different varieties of it. The program concludes at the end of this year but leaves science with technologies to address some of the biggest bottlenecks encountered by researchers in the niche field of study

    Dec 19, 2023
  • Illumina to Divest GRAIL Business by Q2 2024

    Diagnostics World | On Sunday, Illumina announced that the company will divest GRAIL.

    Dec 17, 2023
  • Novel DNA Methylation Markers, Biosensor Aim for Early Detection of Cervical Cancer

    Diagnostics World |An international research consortium led by scientists from LMU University Hospital Munich has tested a new simple, rapid tuberculosis test that uses a blood sample from the fingertip. The candidate test, called the Cepheid Mycobacterium tuberculosis Host Response prototype cartridge (MTB-HR), works by measuring a three-gene transcriptomic signature.

    Dec 14, 2023
  • Living Biobank Of Brain Metastasis Samples Enabling ‘Personalized Medicine 2.0’

    Diagnostics World |Researchers at the CNIO (Spanish National Cancer Research Centre) are forwarding the idea that metastasis, rather than the primary tumor, should be the focus of cancer treatment, which would both further the cause of personalized medicine and generate biomarkers of sensitivity or resistance to specific drugs.

    Dec 13, 2023
  • Finger Prick Test Aims to Simplify Childhood Tuberculosis Diagnosis

    Diagnostics World |An international research consortium led by scientists from LMU University Hospital Munich has tested a new simple, rapid tuberculosis test that uses a blood sample from the fingertip. The candidate test, called the Cepheid Mycobacterium tuberculosis Host Response prototype cartridge (MTB-HR), works by measuring a three-gene transcriptomic signature.

    Dec 12, 2023